ClinicalTrials.gg
RecruitingNCT06462040OC-FIXUpdated Jan 30, 2026

Evaluation of Clinical and Radiological Outcomes in Patients Undergoing Fixation of Osteochondral Fragments With Reasorbable Screws in the Knee Joint

An observational study in Osteochondral Defect, Osteochondritis Dissecans and Osteochondral Fracture, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 12 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by Istituto Ortopedico Rizzoli · Observational

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
100
Ages
12 Years to 35 Years
Sex
All
01

Study summary

Various techniques for the fixation of unstable osteochondral fragments have been used over the years, each with associated advantages and disadvantages, and differing clinical outcomes. However, the literature on the treatment of this type of injury in the adolescent and young adult population is scarce and involves small case series. Failure to treat these injuries can lead to serious consequences such as chronic pain, residual joint stiffness, and the development of early osteoarthritis, necessitating more invasive and burdensome interventions for the national health system, such as prosthetic replacements or osteotomies.

Due to the lack of real consensus within the scientific community regarding the ideal treatment for these patients and the insufficient medium/long-term follow-up data on the effects of these injuries on articular cartilage in young patients, this study aims to evaluate the clinical and radiological conditions of patients undergoing osteochondral fragment fixation using the same surgical technique (fixation with resorbable screws performed arthroscopically or via open surgery depending on the lesion's location) in order to clarify preventive measures against cartilage degeneration following these injuries, which are very common in adolescence.

02

Conditions studied

  • Osteochondral Defect
  • Osteochondritis Dissecans
  • Osteochondral Fracture
  • Osteochondral Fracture of Patella
03

In context

Osteochondritis Dissecans

30 studies on the registry are indexed under Osteochondritis Dissecans; 7 are open to participants now.

This study's planned enrollment of 100 is below the median of 130 across 12 observational studies indexed under Osteochondritis Dissecans.

Browse Osteochondritis Dissecans studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients will be recruited from all subjects who have already undergone surgical treatment for fixation of knee osteochondral fragments using resorbable screws since 2017, and all new patients eligible for this type of intervention until 2025 at the Orthopedic and Traumatology Clinic II of the Rizzoli Orthopedic Institute.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients undergoing surgical fixation of osteochondral fragment using resorbable screw technique, either arthroscopically or via mini-open procedure depending on the lesion's location, from 01/01/2017, and all new patients eligible for this type of intervention until 31/12/2025.
  2. Patients aged between 12 and 35 years at the time of the surgical intervention.
  3. Patients with the presence of osteochondral fragments confirmed by magnetic resonance imaging.
  4. Patients with osteochondral lesions observed on imaging and symptoms attributable to the presence of osteochondral fragments.
  5. Patients diagnosed with osteochondritis dissecans or recent contusion/sprain trauma.

Exclusion criteria

Exclusion Criteria:

  1. Patients with concomitant complex ligamentous injuries or fractures at the time of the intervention;
  2. Patients who are no longer reachable;
  3. Women of childbearing age who cannot exclude pregnancy;
  4. Patients who are unable to provide or patients who are unwilling to sign the informed consent form.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
100 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • ProcedureFixation of osteochdral fragments with reabsorbable screws

    Arthroscopic or mini-open fixation of free-intrarticular or unstable osteochondral fragments due to osteochondritis dissecans or osteochondral fractures with reabsorbable screws

06

What researchers measure

Primary outcomes

  1. KOOS (Knee Injury and Ostearthritis Outcome Score) score

    It represents a subjective score composed of 42 questions divided into 5 main domains. These domains investigate various aspects of symptoms and daily activities as well as the quality of life related to the knee and are divided as follows: * Symptoms, composed of 7 questions, 2 of which pertain to stiffness; * Pain, composed of 9 questions; * Functions and daily activities, composed of 17 questions; * Sports and recreational activities, composed of 5 questions; * Quality of life in relation to the knee, composed of 4 questions. All questions use the same response format, utilizing a quantitative scale ranging from 0 (no issues) to 4 (severe difficulty). Scores are calculated separately for each domain and converted into a percentage score, where 100 represents excellent physical condition with no symptoms and 0 represents severe disability with limitations in daily activities and constant symptoms even at rest.

    Time frame: At least 24 months after surgery

Secondary outcomes

  1. Kujala Anterior Knee Pain Scale

    The Kujala score is a subjective knee assessment tool that quantifies limitations in daily and sports activities, as well as the presence or absence of symptoms. The questionnaire consists of 13 multiple-choice questions, with a total score ranging from 0 to 100. Each question has a variable score from 5 to 10 points and includes 3, 4, or 5 multiple-choice answers. The topics covered by each question include limping, pain, swelling, flexion deficit, and difficulty performing various types of activities. The maximum score of 100 represents no limitations or symptoms; the further the score deviates from 100, the worse the outcome.

    Time frame: At least 24 months after surgery

  2. International Knee Documentation Committee (IKDC) Score

    The IKDC score is a subjective knee assessment tool that assesses limitations in daily and sports activities, as well as the presence or absence of symptoms. The IKDC score comprises three main domains: 1. Symptoms, which include pain, stiffness, swelling, and the sensation of locking. 2. Sports and daily activities. 3. Current knee function and function before the injury. The questionnaire consists of 10 questions: * Seven items inquire about the patient's symptoms. * One item focuses on participation in sports. * One item, composed of 9 points, addresses the difficulties the patient experiences in performing daily activities. * The last item measures the current functionality of the knee. Scores range from 0 to 100, where 100 represents the absence of limitations and symptoms. The further the score deviates from 100, the worse the outcome, which can be categorized into four groups: excellent (80-100), good (60-80), fair (30-60), and poor (0-30).

    Time frame: At least 24 months after surgery

  3. Objective IKDC (IKDC standard evaluation form)

    This represents a clinical chart that is completed by the physician following a comprehensive knee examination where various clinical tests are performed to assess for any joint deformities, objective instability, and meniscal injuries. The score obtained determines an objective evaluation grade coded using letters. According to this scale, grade "A" is assigned to a knee with "normal functionality, as healthy," grade "B" is assigned to a knee with "almost normal functionality," grade "C" is assigned to a knee with "moderately abnormal functionality," and grade "D" is assigned to a knee with "severely abnormal functionality."

    Time frame: At least 24 months after surgery

  4. MARX Activity Rating Scale

    The MARX questionnaire is a subjective assessment tool designed to evaluate the activity level of patients with knee disorders who engage in sports. It focuses on four domains of sports activity: running, deceleration, cutting, pivoting. Patients are asked to approximate how many times they have performed each of these activities over the past twelve months. The four knee functions are evaluated on a 5-point frequency scale, and the scores are summed up to a maximum of sixteen points, where a higher score indicates more frequent participation and thus is correlated with a higher knee health status. The MARX questionnaire differs from many other activity measures because it is not based on participation in specific sports activities. Instead, patients are asked about different components of physical function (such as running and pivoting) common to various sports. The aim of this tool is to identify the overall activity level of the patient rather than their most recent activity.

    Time frame: At least 24 months after surgery

  5. VAS (Visual Analog Scale) for pain

    This is a quantitative, one-dimensional numeric pain assessment scale, ranging from 0 to 10. The scale requires the patient to select the number that best describes the intensity of their pain, from 0 to 10, at the time of the visit and before the surgical intervention. 0 indicates no pain, while 10 indicates the worst possible pain.

    Time frame: At least 24 months after surgery

  6. Radiological evaluation (MRI, magnetic resonance imaging) throughout ICRS Cartilage Score

    Assessment of healing of the fragment fixation

    Time frame: 24 months after surgery

  7. Radiological evaluation (MRI, magnetic resonance imaging) throughout Outerbridge Classification

    Healing status of ostechondral fragment

    Time frame: 24 months after surgery

  8. Sports Activity Level, Tegner Score

    Allows estimation of a subject's motor activity level with a score ranging from 0 to 10, where 0 represents 'inability' and 10 represents 'participation in competitive sports, such as national or international-level soccer. This score is commonly used to define the motor activity level of patients with knee disorders. Additionally, patients will be asked how many years they have been active in sports and whether the reduction or cessation of activity is related to knee pathology or not.

    Time frame: At least 24 months after surgery

  9. Thigh circumference

    Measuring the circumference of the thigh at 5 cm and 15 cm from the superior pole of the patella allows for the evaluation of the degree of muscle trophism of the subjects under examination, and thus the potential influence of the type of technique used on muscle trophism.

    Time frame: At least 24 months after surgery

  10. Anterior knee pain / pain during knee flexion

    In order to specifically assess the symptoms of the patellofemoral joint, patients will be asked to respond to these questions dichotomously (YES/NO).

    Time frame: At least 24 months after surgery

  11. Likert scale

    In order to assess the level of patient satisfaction, they will be asked to respond to a question composed of 5 levels of satisfaction (from 1 to 5), where 1 indicates that the patient is very satisfied with the intervention, while 5 indicates a high degree of dissatisfaction.

    Time frame: At least 24 months after surgery

  12. Complications, subsequent interventions, or surgical failures

    Any complications, subsequent interventions, and surgical failures will be documented and recorded in the CRF.

    Time frame: At least 24 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — In the first phase, specialized medical personnel will identify eligible subjects within the hospital database. For retrospective cohorts, patients with provided contact details will be contacted, ensuring their consent for research participation. Interested patients will schedule a follow-up visit, during which they\'ll receive informational material and provide informed consent. Patients undergoing revision surgery or with septic arthritis will be considered surgical failures and excluded from follow-up. In the second phase, patients, after signing consent, will undergo clinical evaluation at least 24 months post-surgery, focusing on subjective assessments and clinical-instrumental tests. Knee MRI will evaluate radiological healing, with MRIs performed if documentation is unavailable. Visits will occur at the research clinic, and data will be recorded in Case Report Forms. The data will be entered into the RedCap Database.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Jun 2028, 45 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2024
First posted
Jun 17, 2024
StartActual
Sep 25, 2024
Primary completionEst.
Jun 2028
CompletionEst.
Jun 2028
Last update
Jan 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06462040
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Principal investigator
First posted
Jun 17, 2024
Start date
Sep 25, 2024
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Jan 30, 2026

Study contacts

Stefano Zaffagnini
Contact
stefano.zaffagnini@ior.it
0516366075

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion